Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Gadsden, AL – FDA Inspections
Inspection records and compliance data for Linde Inc in Gadsden, Alabama. 2 FDA inspections on record, last inspected July 13, 2026. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Gadsden, Alabama, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected April 1, 2014. Last inspected July 13, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 13, 2026 | Not classified | Human Drugs | 1328774 |
| April 1, 2014 | NAI | Human Drugs · Drug Quality Assurance | 872597 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1046137
Address
412 Vandell Blvd, Gadsden, Alabama 35904, United States
Country
United States
ID: 25dd5928-c858-478a-bb1c-8d8621c6992c